FI950420A0 - Kiteiset amifostiinikoostumukset sekä niiden valmistusmenetelmät ja käyttö - Google Patents

Kiteiset amifostiinikoostumukset sekä niiden valmistusmenetelmät ja käyttö

Info

Publication number
FI950420A0
FI950420A0 FI950420A FI950420A FI950420A0 FI 950420 A0 FI950420 A0 FI 950420A0 FI 950420 A FI950420 A FI 950420A FI 950420 A FI950420 A FI 950420A FI 950420 A0 FI950420 A0 FI 950420A0
Authority
FI
Finland
Prior art keywords
amyphostine
crystalline
compositions
preparation
methods
Prior art date
Application number
FI950420A
Other languages
English (en)
Swedish (sv)
Other versions
FI950420A (fi
FI117924B (fi
Inventor
Paul E Kennedy
Roger A Rajewski
John M Baldoni
Original Assignee
Us Bioscience
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25447813&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI950420(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Us Bioscience filed Critical Us Bioscience
Publication of FI950420A0 publication Critical patent/FI950420A0/fi
Publication of FI950420A publication Critical patent/FI950420A/fi
Application granted granted Critical
Publication of FI117924B publication Critical patent/FI117924B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/16—Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165—Esters of thiophosphoric acids
    • C07F9/1651—Esters of thiophosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI950420A 1992-07-31 1995-01-31 Kiteisten amifostiinikoostumuksien valmistusmenetelmät FI117924B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US92292992A 1992-07-31 1992-07-31
US92292992 1992-07-31
US9307222 1993-07-30
PCT/US1993/007222 WO1994003179A1 (en) 1992-07-31 1993-07-30 Crystalline amifostine compositions and methods for the preparation and use of same

Publications (3)

Publication Number Publication Date
FI950420A0 true FI950420A0 (fi) 1995-01-31
FI950420A FI950420A (fi) 1995-03-31
FI117924B FI117924B (fi) 2007-04-30

Family

ID=25447813

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950420A FI117924B (fi) 1992-07-31 1995-01-31 Kiteisten amifostiinikoostumuksien valmistusmenetelmät

Country Status (8)

Country Link
US (1) US5424471A (fi)
EP (2) EP1764103A3 (fi)
KR (1) KR100297613B1 (fi)
FI (1) FI117924B (fi)
HK (1) HK1049280A1 (fi)
MY (1) MY110631A (fi)
WO (1) WO1994003179A1 (fi)
ZA (1) ZA935532B (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051563A (en) * 1997-02-12 2000-04-18 U.S. Bioscience, Inc. Methods for the administration of amifostine and related compounds
US6573253B2 (en) 1997-02-12 2003-06-03 Medimmune Oncology Inc. Methods for the administration of amifostine and related compounds
US5994409A (en) * 1997-12-09 1999-11-30 U.S. Bioscience, Inc. Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds
US6239119B1 (en) * 1998-04-27 2001-05-29 Medimmune Oncology, Inc. Topical administration of amifostine and related compounds
US6017922A (en) 1998-05-18 2000-01-25 U.S. Bioscience, Inc. Thermally stable trimetrexates and processes for producing the same
US6407278B2 (en) * 1998-11-16 2002-06-18 Medimmune Oncology, Inc. Stable amorphous amifostine compositions and methods for the preparation and use of the same
US6384259B1 (en) * 1998-11-16 2002-05-07 Medimmune Oncology, Inc. Stable amorphous amifostine compositions and dosage form
DK2193809T3 (en) 1999-02-22 2015-05-26 Univ Connecticut The albumin-free Factor VIII formulation
AU2001253919B2 (en) 2000-04-26 2006-12-14 Government Of The United States, D/B/A Department Of Veterans Affairs Administration of a thiol-based chemoprotectant compound
DE10043170C2 (de) * 2000-09-01 2002-10-24 Klinge Co Chem Pharm Fab Amifostin-Monohydrat und Verfahren zu seiner Herstellung
US7053072B2 (en) 2001-05-11 2006-05-30 Medimmune Oncology, Inc. Methods for the administration of amifostine and related compounds
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
US7629333B2 (en) * 2002-03-29 2009-12-08 Medimmune, Llc Stable amorphous amifostine compositions and methods for the preparation and use of same
SE522981C2 (sv) * 2002-07-01 2004-03-23 Nobel Biocare Ab Anordning och metod för att bibehålla nybensbildande effekt hos tillväxtstimulerande substanser vid implantatprodukt
US7604967B2 (en) * 2003-03-19 2009-10-20 The Trustees Of Dartmouth College Lignin-blocking treatment of biomass and uses thereof
JP2007511517A (ja) * 2003-11-14 2007-05-10 アルザ・コーポレーシヨン 薬剤と照射を受けた賦形剤の製剤の中の薬剤の酸化を最小化
US20050187608A1 (en) * 2004-02-24 2005-08-25 O'hara Michael D. Radioprotective compound coating for medical devices
BRPI0509117A (pt) * 2004-03-04 2007-08-28 Wyeth Corp método de liofilização para melhorar a cristalização de excipientes
US7956160B2 (en) * 2005-07-22 2011-06-07 Amgen Inc. Concentrated protein lyophilates, methods, and uses
TW200716504A (en) * 2005-10-18 2007-05-01 jin-zhi Ye The orthopaedic implant products with controllable dissolving rate for biomedical use and the manufacturing method thereof
WO2007047315A1 (en) * 2005-10-20 2007-04-26 Albemarle Corporation Amifostine dihydrate crystalline composition
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
WO2007096901A1 (en) * 2006-02-24 2007-08-30 Natco Pharma Limited Novel dihydrate form of amifostine and process for its preparation
US20090239817A1 (en) * 2006-04-17 2009-09-24 Goverment Of The United States Of America, As Represented By The Secretary, Dept Of Health Organic thiophosphate antiretroviral agents
US9585849B2 (en) * 2006-04-17 2017-03-07 The Burlington Hc Research Group, Inc. Broad spectrum antiviral and methods of use
WO2008060441A2 (en) * 2006-11-09 2008-05-22 Scidose Llc Stable amifostine liquid concentrate
MX339060B (es) 2008-11-07 2016-05-09 Baxter Int Formulaciones del factor viii.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892824A (en) * 1968-12-16 1975-07-01 Southern Res Inst S-{107 -({107 -aminoalkylamino)alkyl dihydrogen phosphorothioates
JPS544672A (en) * 1977-06-10 1979-01-13 Taiyo Shokai Co Ltd Method and device for making material band for gusset pouch
JPS6041676B2 (ja) * 1977-09-21 1985-09-18 山之内製薬株式会社 Ｓ−２−（３−アミノプロピルアミノ）エチルジハイドロジエンホスホロチオエ−ト１水和結晶の新規製法
US4424216A (en) * 1979-07-31 1984-01-03 The Rockefeller University Method for the reduction of mucin viscosity
DD289448A7 (de) 1982-07-29 1991-05-02 Amt Fuer Atomsicherheit Und Strahlenschutz,De Verfahren zur herstellung von s-[2-(3-amino-propylamino)ethyl]-dihydrogenthiophosphat
DD289449A7 (de) 1983-07-29 1991-05-02 Amt Fuer Atomsicherheit Und Strahlenschutz,De Verfahren zur herstellung von s-[2-(3-amino-propylamino)ethyl]-dihydrogenthiophosphat
EP0192660B1 (en) * 1984-08-08 1992-11-19 Survival Technology, Inc. Absorption enhancing agents
JPH04505760A (ja) 1989-05-24 1992-10-08 ユー・エス・バイオサイエンス Ａｚｔの副作用および毒性からの保護方法

Also Published As

Publication number Publication date
EP1764103A2 (en) 2007-03-21
KR950702424A (ko) 1995-07-29
WO1994003179A1 (en) 1994-02-17
HK1049280A1 (zh) 2003-05-09
KR100297613B1 (ko) 2001-10-24
EP1243272A3 (en) 2003-01-22
ZA935532B (en) 1994-02-24
US5424471A (en) 1995-06-13
FI950420A (fi) 1995-03-31
FI117924B (fi) 2007-04-30
EP1243272A2 (en) 2002-09-25
EP1764103A3 (en) 2011-08-24
MY110631A (en) 1998-09-30

Similar Documents

Publication Publication Date Title
FI950420A (fi) Kiteiset amifostiinikoostumukset sekä niiden valmistusmenetelmät ja käyttö
FI931163A0 (fi) Kompositioner innehaollande kombinationer av ytaktiva medel och baernstensyraacyleringsmedelderivat eller hydroxiaromatiska aemnen och anvaendning av dessa
SE9301347A0 (sv) Antiskummedel-komposition av emulsionstyp och sätt för skumbekämpning användande densamma
FI972245A (fi) Meso-monojodisubstituoidut tetramakrosykliset yhdisteet sekä niiden valmistus- ja käyttömenetelmät
FI934839A0 (fi) Foerfarande och anordning foer aoterstaellning av klockan i en skillnadsmottagare
MX9205721A (es) Metodo de uso y composiciones de win 49596-finasteride
FI931817A0 (fi) Jonkomplex av joniserbara emulgatorer med joniserbara polypeptider och/eller joniserbara hydrokolloidala medel
FI931161A0 (fi) Kompositioner innehaollande estrar av karboxylhaltiga interpolymerer och anvaendning av dessa
FI940775A (fi) alfa-fenyyli-isoseriinijohdannaisten valmistusmentelmä ja niiden käyttö
FI942963A (fi) Imidatsokinatsoliiniyhdisteitä ja niiden valmistus ja käyttö
FI934336A0 (fi) Foerfarande och anordning foer bestaemning av servande kommunikationssystem vid sammankopplad funktion av kommunikationssystem
FI933540A (fi) Foerfarande och anordning foer vaermebehandling av en matprodukt i en aongatmosfaer
DK475187D0 (da) Delta22-derivater af ll-f28249-forbindelser samt anvendelse deraf
FI935789A0 (fi) Anlaeggning och foerfarande foer braenning av explosiva aemnen
SE458083B (sv) Elradiator och anvaendning av densamma
FI922139A (fi) Foerfarande och anordning foer framstaellning av anhydrit-stygips
NO178213C (no) Anvendelse av en antimikrobiologisk sammensetning
FI932863A0 (fi) Foerfarande foer framstaellning av nya tienotiazinderivat och deras anvaendning
NO940190D0 (no) Anvendelse av x-ketoglutarat
FI944316A0 (fi) Koostumuksia ja tapa kovien pintojen puhdistamiseksi niiden laimennoksilla
FI920758A (fi) Komposition och dessa anvaendning saosom biocid
FI943213A (fi) Prosessi valmistaa 3-asyyliestratrieenejä ja asyylibentseenejä
FI910207A (fi) Fungisidisia vaikuttavien aineiden yhdistelmiä
FI942139A (fi) Pyranyylisyaaniguanidiinijohdannaisten valmistuksessa käyttökelpoisia välituotteita ja menetelmiä niiden valmistamiseksi
FI915097A (fi) Komposition och foerfarande foer konservering av traed

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117924

Country of ref document: FI

MA Patent expired